Get the Stockscreener App
31.55
5.73%
1.71
Azenta Inc stock is traded at $31.55, with a volume of 531.30K.
It is up +5.73% in the last 24 hours and down -4.16% over the past month.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.
See More
Previous Close:
$29.84
Open:
$30.18
24h Volume:
531.30K
Relative Volume:
0.65
Market Cap:
$1.45B
Revenue:
$604.93M
Net Income/Loss:
$-31.91M
P/E Ratio:
-13.04
EPS:
-2.42
Net Cash Flow:
$45.67M
1W Performance:
+3.82%
1M Performance:
-4.16%
6M Performance:
-29.50%
1Y Performance:
-34.00%
1-Day Range:
$29.97
$31.80
1-Week Range:
$29.14
$31.80
52-Week Range:
$23.91
$55.63
Azenta Inc Stock (AZTA) Company Profile
Name
Azenta Inc
Sector
Industry
Phone
(978) 262-2400
Address
200 SUMMIT DRIVE, BURLINGTON
Compare AZTA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AZTA
Azenta Inc
|
31.55 | 1.39B | 604.93M | -31.91M | 45.67M | -2.42 |
|
ISRG
Intuitive Surgical Inc
|
476.16 | 172.53B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
199.66 | 55.89B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
82.02 | 43.59B | 9.93B | 1.12B | 1.43B | 2.26 |
|
RMD
Resmed Inc
|
293.73 | 41.89B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
247.85 | 17.48B | 2.96B | 487.70M | 344.00M | 6.68 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-06-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jul-22-25 | Resumed | Stephens | Equal-Weight |
| Dec-18-24 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-04-24 | Initiated | Jefferies | Hold |
| Feb-01-24 | Reiterated | B. Riley Securities | Buy |
| Jul-19-23 | Initiated | Raymond James | Mkt Perform |
| May-10-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-09-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-31-22 | Resumed | B. Riley Securities | Buy |
| Mar-21-22 | Initiated | Evercore ISI | Outperform |
View All
Azenta Inc Stock (AZTA) Latest News
Resistance Break Could Fuel Azenta Inc. Rally2025 Historical Comparison & Free Community Supported Trade Ideas - news-j.co.kr
What Fibonacci levels say about Azenta Inc. reboundWeekly Gains Report & Real-Time Volume Analysis - Newser
Has Azenta Inc. formed a bullish divergence2025 Market Overview & Risk Managed Investment Entry Signals - Newser
Is Azenta Inc. meeting your algorithmic filter criteria2025 Winners & Losers & Daily Growth Stock Investment Tips - Newser
Measuring Azenta Inc.’s beta against major indicesJuly 2025 Drop Watch & Accurate Buy Signal Alerts - Newser
Understanding Azenta Inc.’s price movement2025 Biggest Moves & Community Consensus Picks - Newser
Azenta Inc. stock chart pattern explainedJuly 2025 Drop Watch & Low Drawdown Trading Techniques - Newser
Tick level data insight on Azenta Inc. volatilitySell Signal & AI Based Trade Execution Alerts - Newser
What earnings revisions data tells us about Azenta Inc.Analyst Downgrade & Community Verified Watchlist Alerts - Newser
US Bancorp DE Sells 816 Shares of Azenta, Inc. $AZTA - Defense World
How Azenta Inc. stock performs during market volatilityPortfolio Profit Report & Verified Swing Trading Watchlists - Newser
Is Azenta Inc. part of any major indexMarket Growth Review & Long-Term Safe Investment Ideas - mustnews.co.kr
Published on: 2025-08-17 14:18:13 - Newser
What MACD and RSI say about Azenta Inc.Market Sentiment Report & Real-Time Volume Analysis - Newser
What data driven models say about Azenta Inc.’s futureJuly 2025 Fed Impact & Expert Approved Momentum Trade Ideas - Newser
New Product Launches: Will They Boost Azenta Inc. Stock in 2025Market Growth Review & Risk Controlled Swing Alerts - Newser
Visual analytics tools that track Azenta Inc. performanceWeekly Gains Report & Free Daily Entry Point Trade Alerts - Newser
Is Azenta Inc. a top pick in the sectorGap Down & High Accuracy Buy Signal Tips - thegnnews.com
Short interest data insights for Azenta Inc.Jobs Report & Precise Swing Trade Alerts - Newser
The Market Doesn't Like What It Sees From Azenta, Inc.'s (NASDAQ:AZTA) Revenues Yet - 富途牛牛
Intraday Charts Show Spike in Azenta Inc. ActivityJuly 2025 Technicals & High Yield Stock Recommendations - beatles.ru
Azenta, Inc. (NASDAQ:AZTA) Shares Sold by XTX Topco Ltd - Defense World
Azenta, LifeStance Health Group, BioMarin Pharmaceutical, AMN Healthcare Services, and ANI Pharmaceuticals Stocks Trade Up, What You Need To Know - Yahoo Finance
Azenta, LifeStance Health Group, BioMarin Pharmaceutical, AMN Healthcare Services, and ANI Pharmaceuticals Stocks Trade Up, What You Need To Know | FinancialContent - FinancialContent
Azenta (AZTA) Surges 9.6% Intraday: What's Fueling This Healthcare Tech Rally? - AInvest
Can Azenta’s (AZTA) Genomics Partnership Reframe Its Long-Term Growth Story? - simplywall.st
Azenta EVP Lin buys $69,900 in shares By Investing.com - Investing.com Australia
Azenta EVP Lin buys $69,900 in shares - Investing.com
Revvity, Avantor, Azenta, Bio-Techne, and Amneal Shares Skyrocket, What You Need To Know - TradingView
How to forecast Azenta Inc. trends using time seriesStock Entry Point Planner with Volume Spike - Newser
Smart tools for monitoring Azenta Inc.’s price actionFree Earnings Play Trade Plan With Alerts - Newser
Volume spikes in Azenta Inc. stock – what they meanTechnical Entry Plan with Risk Minimization - Newser
Azenta upgraded to Outperform from Market Perform at Raymond James - MSN
What makes Azenta Inc. stock price move sharplyHigh Return in Low Timeframe - thegnnews.com
Should I trade or invest in Azenta Inc.Big Money Stock Playbook - mustnews.co.kr
Raymond James Financial Upgrades Azenta (NASDAQ:AZTA) to “Outperform” - Defense World
Evercore ISI Reiterates “$33.00” Price Target for Azenta (NASDAQ:AZTA) - Defense World
Why Azenta (AZTA) Stock Is Up Today - TradingView
Azenta 2025 Q3 Earnings Deepening Losses Amid Flat Revenue - AInvest
Azenta, Inc. (NASDAQ:AZTA) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates - simplywall.st
Evercore ISI Has Lowered Expectations for Azenta (NASDAQ:AZTA) Stock Price - Defense World
Azenta (NASDAQ:AZTA) Trading 8.8% Higher on Strong Earnings - Defense World
Azenta Inc Q3 2025 Earnings Call Highlights: Robust Financial Position Amid Revenue Challenges - AInvest
Azenta, Inc. Earnings Call: Balancing Growth and Challenges - The Globe and Mail
Optimistic Buy Rating for Azenta: Margin Improvements and Market Potential Highlighted - TipRanks
Azenta reaffirms 3%–5% organic growth and 300bps margin expansion for 2025 as operational turnaround advances - MSN
Azenta, Inc. SEC 10-Q Report - TradingView
Azenta (AZTA) Stock Trades Up, Here Is Why - TradingView
Azenta, Inc. (NASDAQ:AZTA) Q3 2025 Earnings Call Transcript - Insider Monkey
Raymond James Upgrades Azenta to Outperform From Market Perform - MarketScreener
Azenta's Q3 2025 Earnings Call: Unpacking Contradictions in NIH Funding, Growth Projections, and Market Dynamics - AInvest
Azenta Inc Stock (AZTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Azenta Inc Stock (AZTA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hughes Violetta | VP, Chief Accounting Officer |
Feb 03 '25 |
Sale |
52.97 |
317 |
16,791 |
9,603 |
| Zhou Ginger | SVP and General Manager, Genom |
Jan 31 '25 |
Buy |
45.88 |
417 |
19,132 |
27,916 |
| Pirogova Olga | SVP and CHRO |
Nov 19 '24 |
Sale |
40.07 |
548 |
21,958 |
19,373 |
| Hughes Violetta | VP, Chief Accounting Officer |
Nov 19 '24 |
Sale |
40.07 |
163 |
6,531 |
9,920 |
| Zhou Ginger | SVP and General Manager, Genom |
Nov 19 '24 |
Sale |
40.07 |
491 |
19,674 |
27,499 |
| Wang David Dong | SVP & GM, SMS |
Nov 19 '24 |
Sale |
40.07 |
348 |
13,944 |
24,114 |
| Joseph Jason | SVP, General Counsel, Secy. |
Nov 19 '24 |
Sale |
40.07 |
1,139 |
45,640 |
112,564 |
| Cueto Herman | EVP, Chief Financial Officer |
Nov 19 '24 |
Sale |
40.07 |
712 |
28,530 |
23,892 |
| Marotta John | President and CEO |
Nov 18 '24 |
Buy |
39.48 |
12,717 |
502,066 |
99,612 |
| Marotta John | President and CEO |
Nov 19 '24 |
Buy |
40.67 |
1,250 |
50,838 |
100,862 |
6.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):